I’ve heard (and watched) several interviews with the vivacious Elizabeth (Liz) Parrish. Recently I heard her twice on The Future Tech Podcast. I found the first interview to be very concise and therefore introductory for people not yet familiar with gene therapy as an emergent tool to treat biological aging (regenerative medicine). In 2015, Liz flew to Bogotá (Columbia) and... Read MoreAnti-Aging Gene Therapies—Elizabeth Parrish (CEO, BioViva)
In this sixth episode, Tommy Wood, CSO Nourish Balance Thrive, explains that the majority of modern disease is caused by our environment and as such, under our control. He shares his experience that A.I. coupled with ordinary blood tests, can inform us of changes we can make to protect/optimize our health, or when sick, lower the cost by predicting which further tests to conduct.
Lee: Hello, and welcome to the Hyper Wellbeing podcast, Tommy. Tommy: Oh, thanks for having me. Lee: Tommy, let’s just jump in here. You still look young, you’ve got a fantastic resume, or as the British would say, I think, curriculum vitae. Where is the motivation coming from? What’s your driving force? What’s the mission you’re on? Tommy: I guess... Read MoreEngineering Sustained Health Using A.I. & Standard Blood Chemistry – EP06: Tommy Wood (NBT)
In this fifth episode, Don Brown, CEO LifeOmic, explains the nomenclature shift from precision medicine to precision health, details the firm footing his company has in precision health, how it’s now extending another foot forwards into hyper wellbeing. Lots of app, lifestyle medicine, lifespan, healthspan and biological age quantification chat.
Lee: Hi, so you’re CEO of LifeOmic, a company which I have been tracking for some time. Could you be so kind as to introduce, to give a brief introduction to LifeOmic? Don: Yeah, I started LifeOmic almost two or so years ago. I went through a combined degree in the PhD program many years ago and ended up taking... Read MorePrecision Medicine vs Precision Health vs Hyper Wellbeing – EP05: Don Brown (LifeOmic)